Healthcare reality of the treatment of the high-risk multiple myeloma in Spain

被引:2
作者
Hernandez-Rivas, Jose-Angel [1 ,2 ]
Gironella Mesa, Mercedes [3 ,4 ]
机构
[1] Hosp Univ Infanta Leonor, Serv Hematol & Hemoterapia, Madrid, Spain
[2] Univ Complutense Madrid, Dept Med, Madrid, Spain
[3] Hosp Univ Vail dHebron, Serv Hematol, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
来源
MEDICINA CLINICA | 2020年 / 154卷 / 08期
关键词
LENALIDOMIDE PLUS DEXAMETHASONE; TREATMENT STRATEGIES; CONSENSUS; STRATIFICATION; CARFILZOMIB; GUIDELINES; MANAGEMENT; SURVIVAL;
D O I
10.1016/j.medcli.2019.10.006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:315 / 319
页数:5
相关论文
共 50 条
[21]   Cytogenetic and clinical marks for defining high-risk myeloma in the context of bortezomib treatment [J].
An, Gang ;
Acharya, Chirag ;
Deng, Shuhui ;
Yi, Shuhua ;
Xu, Yan ;
Qin, Xiaoqi ;
Sui, Weiwei ;
Li, Zengjun ;
Shi, Lihui ;
Zang, Meirong ;
Feng, Xiaoyan ;
Hao, Mu ;
Zou, Dehui ;
Zhao, Yaozhong ;
Qi, Junyuan ;
Cheng, Tao ;
Ru, Kun ;
Wang, Jianxiang ;
Tai, Yu-Tzu ;
Qiu, Lugui .
EXPERIMENTAL HEMATOLOGY, 2015, 43 (03) :168-176
[22]   Quantification of clonal circulating plasma cells in newly diagnosed multiple myeloma: implications for redefining high-risk myeloma [J].
Gonsalves, W. I. ;
Rajkumar, S. V. ;
Gupta, V. ;
Morice, W. G. ;
Timm, M. M. ;
Singh, P. P. ;
Dispenzieri, A. ;
Buadi, F. K. ;
Lacy, M. Q. ;
Kapoor, P. ;
Gertz, M. A. ;
Kumar, S. K. .
LEUKEMIA, 2014, 28 (10) :2060-2065
[23]   Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics [J].
Kumar, Shaji ;
Fonseca, Rafael ;
Ketterling, Rhett P. ;
Dispenzieri, Angela ;
Lacy, Martha Q. ;
Gertz, Morie A. ;
Hayman, Suzanne R. ;
Buadi, Francis K. ;
Dingli, David ;
Knudson, Ryan A. ;
Greenberg, Alexandra ;
Russell, Stephen J. ;
Zeldenrust, Steven R. ;
Lust, John A. ;
Kyle, Robert A. ;
Bergsagel, Leif ;
Rajkumar, S. Vincent .
BLOOD, 2012, 119 (09) :2100-2105
[24]   Cardiac biomarkers for risk stratification in newly diagnosed high-risk multiple myeloma in the GMMG-CONCEPT trial [J].
Leypoldt, Lisa B. ;
Guo, Linlin ;
Besemer, Britta ;
Haenel, Mathias ;
Raab, Marc-S. ;
Mann, Christoph ;
Michel, Christian S. ;
Reinhardt, Hans Christian ;
Blau, Igor Wolfgang ;
Goerner, Martin ;
Ko, Yon-Dschun ;
de Wit, Maike ;
Salwender, Hans ;
Scheid, Christof ;
Graeven, Ullrich ;
Peceny, Rudolf ;
Staib, Peter ;
Dieing, Annette ;
Goldschmidt, Hartmut ;
Bokemeyer, Carsten ;
Zeller, Tanja ;
Westermann, Dirk ;
Weisel, Katja C. ;
Twerenbold, Raphael ;
Beitzen-Heineke, Antonia .
CARDIO-ONCOLOGY, 2025, 11 (01)
[25]   High-risk multiple myeloma: Redefining genetic, clinical, and functional high-risk disease in the era of molecular medicine and immunotherapy [J].
Rees, Matthew J. ;
Kumar, Shaji .
AMERICAN JOURNAL OF HEMATOLOGY, 2024, 99 (08) :1560-1575
[26]   Adoptive Immunotherapy and High-Risk Myeloma [J].
Duane, Catherine ;
O'Dwyer, Michael ;
Glavey, Siobhan .
CANCERS, 2023, 15 (09)
[27]   What Is Genomic High-Risk Myeloma? [J].
Davies, Faith E. ;
Walker, Brian A. .
HEMATO, 2022, 3 (02) :287-297
[28]   Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma [J].
Binder, M. ;
Rajkumar, S. V. ;
Ketterling, R. P. ;
Greipp, P. T. ;
Dispenzieri, A. ;
Lacy, M. Q. ;
Gertz, M. A. ;
Buadi, F. K. ;
Hayman, S. R. ;
Hwa, Y. L. ;
Zeldenrust, S. R. ;
Lust, J. A. ;
Russell, S. J. ;
Leung, N. ;
Kapoor, P. ;
Go, R. S. ;
Gonsalves, W. I. ;
Kyle, R. A. ;
Kumar, S. K. .
BLOOD CANCER JOURNAL, 2017, 7 :e600-e600
[29]   Refining High-Risk Multiple Myeloma: Advancements in Genomic, Clinical, and Prognostic Criteria [J].
Martino, Enrica Antonia ;
Mele, Giuseppe ;
Vigna, Ernesto ;
Morabito, Fortunato ;
Gentile, Massimo .
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 17 (01)
[30]   Spinal metastases in multiple myeloma: A high-risk subgroup for ISS III patients [J].
Cossu, Giulia ;
Terrier, Louis-Marie ;
Benboubker, Lotfi ;
Destrieux, Christophe ;
Velut, Stephane ;
Francois, Patrick ;
Zemmoura, Ilyess ;
Amelot, Aymeric .
SURGICAL ONCOLOGY-OXFORD, 2018, 27 (02) :321-326